Register
Login:
Share:
Email Facebook Twitter

RNS VIDEO: Reabold Resources #RBD raise £6 million and take stake in Danube Petroleum Watch here

EXCLUSIVE: HemoGenyx are creating blood cancer treatments with US$9 billion market potential


ShareCast News - AIM Bulletin





Elegant Hotels says takeover talks with Melia Hotels have ended

(ShareCast News) - AIM-listed Elegant Hotels noted recent press speculation on Monday and confirmed that it had received an approach from Melia Hotels regarding a possible cash offer.
[4 Dec '17 08:25]

Diversified Gas & Oil acquires 550 Ohio wells

(ShareCast News) - Appalachian Basin-focussed producer Diversified Gas & Oil announced the acquisition of 550 wells in Central Ohio from NGO Development Corporation on Friday.
[1 Dec '17 16:09]

Lekoil confirms production increase at Otakikpo

(ShareCast News) - Africa-focussed oil and gas exploration, development and production company Lekoil announced an increase in current production at the Otakikpo Marginal Field in the OML 11 licence area on Friday.
[1 Dec '17 16:08]

China Medical System puts 3m into Destiny Pharma

(ShareCast News) - Clinical stage biotechnology company Destiny Pharma announced on Friday that China Medical System Holdings has, through its wholly owned subsidiary CMS Medical Venture Investment, invested 3m in Destiny to accelerate the development of its pipeline of drug candidates.
[1 Dec '17 15:43]

Petro Matad financing deal with Bergen terminated

(ShareCast News) - Mongolia-focussed oil explorer Petro Matad announced on Friday that its amended and restated share purchase and convertible securities deed between itself and Bergen Global Opportunity Fund, dated 14 August, has been terminated by the parties by mutual consent.
[1 Dec '17 15:40]

Premaitha Health CEO receives industry accolade

(ShareCast News) - Molecular diagnostics group Premaitha Health confirmed on Friday that its CEO, Dr Stephen Little, has received Bionow's 'Outstanding Contribution' award in recognition of his "significant contribution to the biomedical sector".
[1 Dec '17 15:35]

African Potash enters joint venture with SG

(ShareCast News) - African Potash announced on Friday that, under a memorandum of understanding with the government of the Republic of Congo signed on 2 August, it has entered into a joint venture agreement with SG.
[1 Dec '17 14:34]

Arrow Global finalises acquisition of Mars mortgage business

(ShareCast News) - Credit management service Arrow Global Group finalised its acquisition of Mars Capital's UK and Irish mortgage servicing business on Friday.
[1 Dec '17 14:28]

CentralNic renegotiates terms on SK-NIC acquisition

(ShareCast News) - Software developer CentralNic announced on Friday that after its August acquisition agreement with Slovakian domain registrar SK-NIC had lapsed, the structure of the deal had changed, with the firms entering into a new share purchase agreement (SPA) on 30 November.
[1 Dec '17 13:45]

SkinBioTherapeutics awarded Australian patent for SkinBiotix

(ShareCast News) - Life sciences company SkinBioTherapeutics announced the granting of the first patent for its 'SkinBiotix' technology in Australia on Friday.
[1 Dec '17 13:31]



Categories: AIM Bulletin, Broker Recommendations, Commodities, Company News, Dealings and Holdings, Economic News, Foreign Exchange, International News, Market Report, New Issues, News and Announcements, Press Round-Up, Risers and Fallers, Small Cap News, Technical Analysis, Tips Round-Up, Week Ahead.


Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk




Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.